Global Iron Drugs Market 2023-2027

Description

List of Tables

The iron drugs market is forecasted to grow by USD 3552.86 mn during 2022-2027, accelerating at a CAGR of 9.41% during the forecast period. The report on the iron drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of iron deficiency globally, growing awareness about the importance of iron in maintaining overall health, and the growing geriatric population.

Technavio's iron drugs market is segmented as below:

By Product

Oral drug
IV drug

By Age Group

Adult
Pediatric

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing number of CKD dialysis centers in emerging economies as one of the prime reasons driving the iron drugs market growth during the next few years. Also, growing recent developments related to iron drugs and the increasing use of iron supplements in pregnancy will lead to sizable demand in the market.

The report on the iron drugs market covers the following areas:

Iron drugs market sizing
Iron drugs market forecast
Iron drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading iron drugs market vendors that include Abbott Laboratories, AbbVie Inc., Alinter Group Ltd., Alora Pharmaceuticals LLC, Covis Pharma GmbH, Daiichi Sankyo Co. Ltd., DSE Health Care Solutions Inc., GlaxoSmithKline Plc, Hiral Labs Ltd., McKesson Corp., NovaFerrum, Pharmacosmos AS, Procter and Gamble, Reckitt Benckiser Group Plc, Rockwell Medical Inc., Sanofi SA, Shield Therapeutics plc, Vifor Pharma Management Ltd., Zydus Lifesciences Ltd., and Breckenridge Pharmaceutical Inc.. Also, the iron drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75415

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Age Group
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global iron drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global iron drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Age Group Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Oral drug - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral drug - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral drug - Year-over-year growth 2022-2027 (%)
6.4 IV drug - Market size and forecast 2022-2027
Exhibit 38: Chart on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on IV drug - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on IV drug - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Age Group

7.1 Market segments
Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
7.2 Comparison by Age Group
Exhibit 46: Chart on Comparison by Age Group
Exhibit 47: Data Table on Comparison by Age Group
7.3 Adult - Market size and forecast 2022-2027
Exhibit 48: Chart on Adult - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Adult - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Adult - Year-over-year growth 2022-2027 (%)
7.4 Pediatric - Market size and forecast 2022-2027
Exhibit 52: Chart on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Age Group
Exhibit 56: Market opportunity by Age Group ($ million)
Exhibit 57: Data Table on Market opportunity by Age Group ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 83: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 95: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 112: AbbVie Inc. - Overview
Exhibit 113: AbbVie Inc. - Product / Service
Exhibit 114: AbbVie Inc. - Key news
Exhibit 115: AbbVie Inc. - Key offerings
12.5 Covis Pharma GmbH
Exhibit 116: Covis Pharma GmbH - Overview
Exhibit 117: Covis Pharma GmbH - Product / Service
Exhibit 118: Covis Pharma GmbH - Key offerings
12.6 Daiichi Sankyo Co. Ltd.
Exhibit 119: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 120: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 121: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 122: Daiichi Sankyo Co. Ltd. - Key offerings
12.7 GlaxoSmithKline Plc
Exhibit 123: GlaxoSmithKline Plc - Overview
Exhibit 124: GlaxoSmithKline Plc - Business segments
Exhibit 125: GlaxoSmithKline Plc - Key news
Exhibit 126: GlaxoSmithKline Plc - Key offerings
Exhibit 127: GlaxoSmithKline Plc - Segment focus
12.8 Hiral Labs Ltd.
Exhibit 128: Hiral Labs Ltd. - Overview
Exhibit 129: Hiral Labs Ltd. - Product / Service
Exhibit 130: Hiral Labs Ltd. - Key offerings
12.9 McKesson Corp.
Exhibit 131: McKesson Corp. - Overview
Exhibit 132: McKesson Corp. - Business segments
Exhibit 133: McKesson Corp. - Key offerings
Exhibit 134: McKesson Corp. - Segment focus
12.10 Pharmacosmos AS
Exhibit 135: Pharmacosmos AS - Overview
Exhibit 136: Pharmacosmos AS - Product / Service
Exhibit 137: Pharmacosmos AS - Key offerings
12.11 Procter and Gamble
Exhibit 138: Procter and Gamble - Overview
Exhibit 139: Procter and Gamble - Business segments
Exhibit 140: Procter and Gamble - Key offerings
Exhibit 141: Procter and Gamble - Segment focus
12.12 Reckitt Benckiser Group Plc
Exhibit 142: Reckitt Benckiser Group Plc - Overview
Exhibit 143: Reckitt Benckiser Group Plc - Business segments
Exhibit 144: Reckitt Benckiser Group Plc - Key offerings
Exhibit 145: Reckitt Benckiser Group Plc - Segment focus
12.13 Rockwell Medical Inc.
Exhibit 146: Rockwell Medical Inc. - Overview
Exhibit 147: Rockwell Medical Inc. - Product / Service
Exhibit 148: Rockwell Medical Inc. - Key offerings
12.14 Sanofi SA
Exhibit 149: Sanofi SA - Overview
Exhibit 150: Sanofi SA - Business segments
Exhibit 151: Sanofi SA - Key news
Exhibit 152: Sanofi SA - Key offerings
Exhibit 153: Sanofi SA - Segment focus
12.15 Shield Therapeutics plc
Exhibit 154: Shield Therapeutics plc - Overview
Exhibit 155: Shield Therapeutics plc - Product / Service
Exhibit 156: Shield Therapeutics plc - Key offerings
12.16 Vifor Pharma Management Ltd.
Exhibit 157: Vifor Pharma Management Ltd. - Overview
Exhibit 158: Vifor Pharma Management Ltd. - Product / Service
Exhibit 159: Vifor Pharma Management Ltd. - Key news
Exhibit 160: Vifor Pharma Management Ltd. - Key offerings
12.17 Zydus Lifesciences Ltd.
Exhibit 161: Zydus Lifesciences Ltd. - Overview
Exhibit 162: Zydus Lifesciences Ltd. - Business segments
Exhibit 163: Zydus Lifesciences Ltd. - Key offerings
Exhibit 164: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations